✦ LIBER ✦

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura

✍ Scribed by Peter Brændstrup; Ole W. Bjerrum; Ove J. Nielsen; Bjarne A. Jensen; Nielsaage T. Clausen; Per Boye Hansen; Ivan Andersen; Kai Schmidt; Torben M. Andersen; Niels A. Peterslund; Henrik S. Birgens; Torben Plesner; Bjarne B. Pedersen; Hans C. Hasselbalch

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 81 KB
Volume: 78
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.20276

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Refractory autoimmune thrombocytopenic p

Refractory autoimmune thrombocytopenic purpura: Responses to treatment with a recombinant antibody to lymphocyte membrane antigen CD20 (rituximab)

✍ Mohit Narang; John A. Penner; Dan Williams 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

Rituximab for the treatment of refractor

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases

✍ Lydia Koulova; Doru Alexandrescu; Janice P. Dutcher; Kevin P. O'Boyle; Saji Eape 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Three patients (one with idiopathic thrombocytopenic purpura [ITP] and two with thrombotic thrombocytopenic purpura [TTP]) were treated with rituximab (anti-CD20 chimeric antibody) at a dose of 325 mg/m 2 administered weekly after they failed standard therapies. The patient with ITP who did not resp

Experimental treatment of human diffuse

Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab

✍ Franck Assayag; Nicole Brousse; Jérôme Couturier; Elizabeth Macintyre; Claire Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views